The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bamias, G.
Right arrow Articles by Cominelli, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bamias, G.
Right arrow Articles by Cominelli, F.
The Journal of Immunology, 2002, 169: 5308-5314.
Copyright © 2002 by The American Association of Immunologists

Down-Regulation of Intestinal Lymphocyte Activation and Th1 Cytokine Production by Antibiotic Therapy in a Murine Model of Crohn’s Disease1

Giorgos Bamias, Marco Marini, Christopher A. Moskaluk, Masaru Odashima, William G. Ross, Jesús Rivera-Nieves and Fabio Cominelli2

Digestive Health Center of Excellence, University of Virginia, Charlottesville, VA 22908

Resident intestinal bacteria likely play an important role in the pathogenesis of Crohn’s disease through their interaction with the gut immune system. SAMP1/YitFc mice spontaneously develop chronic, discontinuous, transmural ileitis with many features similar to Crohn’s disease. The aim of this study was to determine the effects and elucidate the mechanisms of action of antibiotic treatment in the SAMP1/YitFc mouse model of ileitis. Mice were treated orally with ciprofloxacin and metronidazole before the development of ileitis (prevention protocol) or after ileitis was fully established (treatment protocol). Terminal ilea were harvested for histological scoring, and lamina propria and mesenteric lymph node cells were isolated for analysis of activation markers and cytokine production. Antibiotic therapy significantly decreased the severity of ileitis both in the prevention (40% reduction, p < 0.05) and the treatment (25% reduction, p < 0.01) protocols, compared with untreated, control mice. These effects were associated with a decreased percentage of CD4+/CD45RBhigh lymphocytes in mesenteric lymph nodes of antibiotic-treated mice, as well as decreased production of IFN-{gamma} (prevention: 0.53 ± 0.21 vs 1.84 ± 0.04 ng/ml, p < 0.05; treatment: 8.4 ± 0.4 vs 12.4 ± 0.7 ng/ml, p < 0.005) and TNF (prevention: 61.5 ± 13 vs 134 ± 19 pg/ml, p < 0.01; treatment: 333.5 ± 11 vs 496 ± 20 pg/ml, p < 0.001). The number of activated lamina propria lymphocytes was also reduced after antibiotic treatment. In conclusion, antibiotic therapy significantly ameliorates the severity of ileitis in SAMP1/YitFc mice by a mechanism involving down-regulation of activated gut lymphocytes and inhibition of intestinal Th1 cytokine production.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
G. Bamias, A. Okazawa, J. Rivera-Nieves, K. O. Arseneau, S. A. De La Rue, T. T. Pizarro, and F. Cominelli
Commensal Bacteria Exacerbate Intestinal Inflammation but Are Not Essential for the Development of Murine Ileitis
J. Immunol., February 1, 2007; 178(3): 1809 - 1818.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. M. Heimesaat, S. Bereswill, A. Fischer, D. Fuchs, D. Struck, J. Niebergall, H.-K. Jahn, I. R. Dunay, A. Moter, D. M. Gescher, et al.
Gram-Negative Bacteria Aggravate Murine Small Intestinal Th1-Type Immunopathology following Oral Infection with Toxoplasma gondii
J. Immunol., December 15, 2006; 177(12): 8785 - 8795.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
C Prantera
Probiotics for Crohn's disease: what have we learned?
Gut, June 1, 2006; 55(6): 757 - 759.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Mueller, T. Terada, I. M. Rosenberg, O. Shibolet, and D. K. Podolsky
Th2 Cytokines Down-Regulate TLR Expression and Function in Human Intestinal Epithelial Cells
J. Immunol., May 15, 2006; 176(10): 5805 - 5814.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
T. S. Olson, B. K. Reuter, K. G-E. Scott, M. A. Morris, X.-M. Wang, L. N. Hancock, T. L. Burcin, S. M. Cohn, P. B. Ernst, F. Cominelli, et al.
The primary defect in experimental ileitis originates from a nonhematopoietic source
J. Exp. Med., March 20, 2006; 203(3): 541 - 552.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
C Mueller and A J Macpherson
Layers of mutualism with commensal bacteria protect us from intestinal inflammation
Gut, February 1, 2006; 55(2): 276 - 284.
[Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
H. K. Takahashi, H. Iwagaki, D. Xue, G. Katsuno, S. Sugita, K. Mizuno, S. Mori, S. Saito, T. Yoshino, N. Tanaka, et al.
Effect of Ciprofloxacin-Induced Prostaglandin E2 on Interleukin-18-Treated Monocytes
Antimicrob. Agents Chemother., August 1, 2005; 49(8): 3228 - 3233.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
F Hoentjen, H J M Harmsen, H Braat, C D Torrice, B A Mann, R B Sartor, and L A Dieleman
Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice
Gut, December 1, 2003; 52(12): 1721 - 1727.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.